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Abstract
Background: Clinical characteristics and complications of Duchenne muscular dystrophy caused
by skeletal and cardiac muscle degeneration are well known. Gastro-intestinal involvement has also
been recognised in these patients. However an acute perforated gastro-duodenal peptic ulcer has
not been documented up to now.
Case presentation: A 26-year-old male with Duchenne muscular dystrophy with a clinical and
radiographic diagnosis of acute perforated gastro-duodenal peptic ulcer is treated non-operatively
with naso-gastric suction and intravenous medication. Gastrointestinal involvement in Duchenne
muscular dystrophy and therapeutic considerations in a high risk patient are discussed.
Conclusion:  Non-surgical treatment for perforated gastro-duodenal peptic ulcer should be
considered in high risk patients, as is the case in patients with Duchenne muscular dystrophy.
Patients must be carefully observed and operated on if non-operative treatment is unsuccessful.
Background
Duchenne muscular dystrophy (DMD) is a fatal X-linked
recessive disease. It is the most common congenital neu-
romuscular disorder of childhood [1]. It's clinical course
and characteristics caused by skeletal and cardiac muscle
degeneration are well known and documented [2]. Pro-
gressive muscle weakness inevitably results in the com-
plete inability to walk around the age of 11 [3]. By the age
of 18 patients are predisposed to serious pulmonary infec-
tions [4]. It leads to death before the age of 30. Gastro-
intestinal involvement is less well known. Dystrophic
changes in smooth muscle of the gastro-intestinal tract
have been implicated in causing gastro-intestinal dysfunc-
tion [5]. We want to present and discuss a patient with
Duchenne muscular dystrophy with a clinical and radio-
graphic diagnosis of acute perforated peptic ulcer. Treat-
ment options for an acute perforated peptic ulcer should
be well considered in a patient at pulmonary and cardiac
risk caused by DMD.
Case presentation
A 26-year-old male has DMD and is non-ambulatory. He
was presented on our emergency department because of
severe sudden onset abdominal pain. Upon presentation
there was sharp constant pain located in the epigastrium,
with nausea and vomiting. Complaints had been present
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for several hours. There were no signs and symptoms of
gastrointestinal bleeding. On physical examination there
was direct tenderness in his abdomen with rebound ten-
derness and guarding. Bowel sounds were absent. His
body temperature was 38, 3°C, there was a tachycardia at
a rate of 150/min and blood pressure was 115/60 mmHg.
A sitting chest radiograph showed free air in the perito-
neum (figure 1).
Previous medical history was without respiratory aid and
no signs of nightly hypoxia, but with recurring episodes of
pneumonia. His functional vital capacity was 30% of the
predicted value. Two years ago he had two episodes of
acute gastric bleeding from peptic ulcer vessels; both diag-
nosed endoscopicaly and subsequently treated with endo-
scopic epinephrine injections with bipolar coaptation.
Thereafter Helicobacter Pylori (HP) eradication therapy
(omeprazole, metronidazole and clarithromycin for 7
days) was given, followed by a continuous use of omepra-
zol and sucralfate. Furthermore he was known to have a
chronically dilated stomach, with recurring episodes of
poor gastric passage and vomiting.
Based on his previous medical history and signs and
symptoms on current presentation a clinical diagnosis of
perforated peptic ulcer was established. The associated
perioperative risks of pulmonary dysfunction and cardiac
failure in this patient were high. Therefore non-operative
treatment for perforated peptic ulcer was started. The
patient was treated with continuous naso-gastric suction
(20 cm H2O) and intravenous omeprazol continuously
and regular doses of intravenous broad-spectrum antibi-
otics aimed at gram positive, gram negative and anaero-
bic-bacteria (Cefuroxim and Metronidazole) were
administered. The patient's symptoms rapidly improved
thereafter. After a five-day period the naso-gastric suction
tube was removed. The pain and nausea had subsided;
there was less direct tenderness in the abdomen and no
rebound tenderness or guarding. Bowel sounds were
present. Body temperature was normal. Oral intake of flu-
ids and solids was started. Twelve days after admission the
patient was dismissed from hospital in good clinical
condition.
Discussion
DMD is caused by a deletion in the dystrophin gene
located on the short arm of the X-chromosome [6]. The
resulting lack of dystrophin causes degeneration of stri-
ated muscle [7]. Respiratory dysfunction caused by dys-
trophic changes in respiratory muscle causing pulmonary
infection is the most common complication in DMD
[8,9]. Dystrophin is also present in smooth muscle. The
involvement of smooth muscle in addition to the progres-
sive dystrophic changes in striated muscle may cause clin-
ical dysfunction of the gastro-intestinal tract [10-12]. Both
gastric dilatation and intestinal pseudo-obstruction have
been described as gastro-intestinal complications in DMD
[13,14]. To provide evidence that smooth muscle is func-
tionally impaired in patients with DMD, Barohn et al.
compared gastric-emptying time between DMD patients
and healthy control subjects. They showed a significant
difference in gastric emptying time in patients with DMD.
Furthermore, on examination at autopsy degeneration
and loss of smooth gastro-intestinal muscle similar to
changes in skeletal and cardiac muscle were found in
DMD patients [15,16]. To our knowledge however there
are no reports on gastro-duodenal (perforated) peptic
ulcer as a complication in DMD.
The common treatment for patients with perforated pep-
tic ulcer is surgical repair [17]. In most cases an omental
patch repair is performed, followed by treatment with H2
receptor antagonists and if indicated HP eradication ther-
apy [18-20]. Non-operative treatment for perforated pep-
tic ulcer can be successful, as first reported by Taylor in
1957. He compared operative and non-operative treat-
ment for perforated peptic ulcer and reported similar mor-
tality rates in both groups (5%) [21]. Crofts et al.
compared the outcome of non-operative treatment with
that of emergency surgery in a randomised trial and
reported an overall mortality rate of 5% in each group and
no significant difference in morbidity [22]. Crofts et al.
conclude that an initial period of non-operative treatment
is safely allowed except in patients over 70 years old [23].
Kaene et al. reported favourable survival rates (2.4% mor-
tality) in a series of 42 patients treated non-operatively
compared with reported surgical mortality [24]. The
importance of careful clinical observation by an experi-
enced surgeon is emphasised in reported literature,
because non-operative treatment should be promptly
abandoned if unsuccessful [21,25,26].
In spite of those reports non-operative treatment has
never really been accepted as standard treatment [17,27].
However in selected cases non-operative treatment for
perforated peptic ulcer may be considered. Boey et al.
identified major medical illness, preoperative shock and
longstanding perforation, as perioperative risk factors
[28]. Based on these risk factors they correctly predicted
the outcome in 93.8% of patients in a series of 259
patients treated operatively for perforated peptic ulcer.
Mortality rate increased with the presence of one, two or
all three risk factors. Boey et al. conclude that non-opera-
tive treatment should be re-evaluated for patients with all
three risk factors because of their uniformly dismal out-
come after surgery [29]. Patients with DMD are at high
risk for perioperative respiratory dysfunction or heart fail-
ure [30-32]. Therefore in this case a non-operative
approach was well considered and proved to be
successful.BMC Surgery 2004, 4 http://www.biomedcentral.com/1471-2482/4/1
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Conclusion
This case demonstrates a gastro-duodenal peptic ulcer as a
possible complication in DMD. Furthermore it illustrates
that in pulmonary and cardiac high risk patients non-
operative treatment for perforated peptic ulcer can be suc-
cessful. If treated non-operatively patients should be care-
fully observed and operated on if non-operative treatment
is unsuccessful.
Competing interests
None declared.
Abbreviations
DMD: Duchenne muscular dystrophy
HP: Helicobacter Pylori
Authors contributions
Brinkman J-M: rewrote the manuscript in 2003.
Van Royen BJ: helped rewriting the manuscript in 2003.
Brinkman J-M and Oddens J: drafted the manuscript in
2001.
Wever J and Olsman JG: read and approved the manu-
script in 2001 and 2003.
Acknowledgements
The authors received written consent from the patient's family.
No financial support was received.
References
1. Emery AE: Population frequencies of inherited neuromuscular
diseases – a world survey. Neuromuscul Disord 1991, 1:19-29.
2. Boland BJ, Silbert PL, Groover RV, Wollan PC, Silverstein MD: Skel-
etal, cardiac, and smooth muscle failure in Duchenne muscu-
lar dystrophy. Pediatr Neurol 1996, 14:7-12.
3. Allsop KG, Ziter FA: Loss of strength and functional decline in
Duchenne's dystrophy. Arch Neurol 1981, 38:406-411.
4. Vignos PJ Jr: Respiratory function and pulmonary infection in
Duchenne muscular dystrophy. Isr J Med Sci 1977, 13:207-214.
5. Barohn RJ, Levine EJ, Olson JO, Mendell JR: Gastric hypomotility
in Duchenne's muscular dystrophy.  N Engl J Med 1988,
319:15-18.
6. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel
LM: Complete cloning of the Duchenne muscular dystrophy
(DMD) cDNA and preliminary genomic organization of the
DMD gene in normal and affected individuals.  Cell 1987,
50:509-517.
7. Boland BJ, Silbert PL, Groover RV, Wollan PC, Silverstein MD: Skel-
etal, cardiac, and smooth muscle failure in Duchenne muscu-
lar dystrophy. Pediatr Neurol 1996, 14:7-12.
8. Vignos PJ Jr: Respiratory function and pulmonary infection in
Duchenne muscular dystrophy. Isr J Med Sci 1977, 13:207-214.
9. Moriuchi T, Kagawa N, Mukoyama M, Hizawa K: Autopsy analyses
of the muscular dystrophies.  Tokushima J Exp Med 1993,
40:83-93.
10. Boland BJ, Silbert PL, Groover RV, Wollan PC, Silverstein MD: Skel-
etal, cardiac, and smooth muscle failure in Duchenne muscu-
lar dystrophy. Pediatr Neurol 1996, 14:7-12.
11. Barohn RJ, Levine EJ, Olson JO, Mendell JR: Gastric hypomotility
in Duchenne's muscular dystrophy.  N Engl J Med 1988,
319:15-18.
12. Lunshof L, Schweizer JJ: [Acute gastric dilatation in Duchenne's
muscular dystrophy]. Ned Tijdschr Geneeskd 2000, 144:2214-2217.
13. Bensen ES, Jaffe KM, Tarr PI: Acute gastric dilatation in Duch-
enne muscular dystrophy: a case report and review of the
literature. Arch Phys Med Rehabil 1996, 77:512-514.
14. Fuger K, Barnert J, Hopfner W, Wienbeck M: Intestinal pseudoo-
bstruction as a feature of myotonic muscular dystrophy. Z
Gastroenterol 1995, 33:534-538.
15. Barohn RJ, Levine EJ, Olson JO, Mendell JR: Gastric hypomotility
in Duchenne's muscular dystrophy.  N Engl J Med 1988,
319:15-18.
16. Bensen ES, Jaffe KM, Tarr PI: Acute gastric dilatation in Duch-
enne muscular dystrophy: a case report and review of the
literature. Arch Phys Med Rehabil 1996, 77:512-514.
17. Holscher AH, Gutschow C, Schafer H, Bollschweiler E: [Conven-
tional surgery in peptic ulcer perforation: indications and
procedure] Konventionelle Chirurgie der Ulkusperforation:
Indikation und Verfahrensweise. Kongressbd Dtsch Ges Chir Kongr
2001, 118:285-288.
18. Singh K, Chhina RS, Ghosh A, Kaura R: Impact of ranitidine on
prognosis after simple closure of perforated duodenal ulcer.
Trop Gastroenterol 1999, 20:90-92.
19. Chu KM, Kwok KF, Law SY, Tuen HH, Tung PH, Branicki FJ  et al.:
Helicobacter pylori status and endoscopy follow-up of
patients having a history of perforated duodenal ulcer. Gas-
trointest Endosc 1999, 50:58-62.
20. Ng EK, Lam YH, Sung JJ, Yung MY, To KF, Chan AC  et al.: Eradica-
tion of Helicobacter pylori prevents recurrence of ulcer after
simple closure of duodenal ulcer perforation: randomized
controlled trial. Ann Surg 2000, 231:153-158.
21. Taylor H: Non-surgical treatment of perforated peptic ulcer.
Gastroenterology 1957, 33:353-368.
22. Crofts TJ, Park KG, Steele RJ, Chung SS, Li AK: A randomized trial
of nonoperative treatment for perforated peptic ulcer. N Engl
J Med 1989, 320:970-973.
23. Crofts TJ, Park KG, Steele RJ, Chung SS, Li AK: A randomized trial
of nonoperative treatment for perforated peptic ulcer. N Engl
J Med 1989, 320:970-973.
24. Keane TE, Dillon B, Afdhal NH, McCormack CJ: Conservative
management of perforated duodenal ulcer.  Br J Surg 1988,
75:583-584.
25. Crofts TJ, Park KG, Steele RJ, Chung SS, Li AK: A randomized trial
of nonoperative treatment for perforated peptic ulcer. N Engl
J Med 1989, 320:970-973.
26. Keane TE, Dillon B, Afdhal NH, McCormack CJ: Conservative
management of perforated duodenal ulcer.  Br J Surg 1988,
75:583-584.
27. Alizadeh N, Buhler L, Huber O, Morel P: [Conservative treat-
ment of gastroduodenal peptic ulcer perforations: indica-
tions and results] Traitement conservateur des perforations
peptiques gastroduodenales: indications et resultats. Schweiz
Med Wochenschr Suppl 1997, 89:17S-19S.
28. Boey J, Choi SK, Poon A, Alagaratnam TT: Risk stratification in
perforated duodenal ulcers. A prospective validation of pre-
dictive factors. Ann Surg 1987, 205:22-26.
29. Boey J, Choi SK, Poon A, Alagaratnam TT: Risk stratification in
perforated duodenal ulcers. A prospective validation of pre-
dictive factors. Ann Surg 1987, 205:22-26.
30. Schmidt GN, Burmeister MA, Lilje C, Wappler F, Bischoff P: Acute
heart failure during spinal surgery in a boy with Duchenne
muscular dystrophy. Br J Anaesth 2003, 90:800-804.
31. Toyota K, Sakura S, Fukuda N, Saito Y: [Epidural anesthesia and
general anesthesia using the cuffed oropharyngeal airway for
an obese patient with Duchenne's muscular dystrophy].
Masui 1999, 48:1343-1346.
32. Reid JM, Appleton PJ: A case of ventricular fibrillation in the
prone position during back stabilisation surgery in a boy with
Duchenne's muscular dystrophy. Anaesthesia 1999, 54:364-367.
Pre-publication history
The pre-publication history for this paper can be accessed
here:Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Surgery 2004, 4 http://www.biomedcentral.com/1471-2482/4/1
Page 5 of 5
(page number not for citation purposes)
http://www.biomedcentral.com/1471-2482/4/1/prepub